NCT01971502View on ClinicalTrials.gov

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Ascending Oral Doses and Effect of Food on the Bioavailability of BI 1060469

PHASE1CompletedINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

February 28, 2014

Study Completion Date

February 28, 2014

Conditions
Healthy
Interventions
DRUG

Placebo to BI 1060469

single rising doses

DRUG

BI 1060469

food effect

DRUG

BI 1060469

single rising doses

Trial Locations (1)

Unknown

1333.1.1 Boehringer Ingelheim Investigational Site, Biberach

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT01971502 - Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Ascending Oral Doses and Effect of Food on the Bioavailability of BI 1060469 | Biotech Hunter | Biotech Hunter